Elisa F Ogawa1, Elizabeth Leritz1,2,3, Regina McGlinchey1,2,3, William Milberg1,2,3, Jonathan F Bean1,3,4. 1. New England Geriatric Research, Education and Clinical Center, VA Boston Healthcare System, Boston, MA, USA. 2. Neuroimaging Research for Veterans Center, Translational Research Center for TBI and Stress Disorders, VA Boston Healthcare System, Boston, MA, USA. 3. Harvard Medical School, Boston, MA, USA. 4. Spaulding Rehabilitation Hospital, Boston, MA, USA.
Abstract
OBJECTIVE: Mobility limitation and cognitive decline are related. Metabolic syndrome (MetS), the clustering of three or more cardiovascular risk factors, is associated with decline in both mobility and cognition. However, the interrelationship among MetS, mobility, and cognition is unknown. This study investigated a proposed pathway where cognition moderates the relationship between MetS and Mobility. METHOD: Adults ages 45-90 years were recruited. MetS risk factors and mobility performance (Short Physical Performance Battery (SPPB) and gait speed) were evaluated. Cognition was assessed using a comprehensive neuropsychological battery. A factor analysis of neuropsychological test scores yielded three factors: executive function, explicit memory, and semantic/contextual memory. Multivariable linear regression models were used to examine the relationship among MetS, mobility, and cognition. RESULTS: Of the 74 participants (average age 61 ± 9 years; 41% female; 69% White), 27 (36%) participants manifested MetS. Mean SPPB score was 10.9 ± 1.2 out of 12 and gait speed was 1.0 ± 0.2 m/s. There were no statistically significant differences in mobility by MetS status. However, increase in any one of the MetS risk factors was associated with decreased mobility performance after adjusting for age and gender (SPPB score: β (SE) -.17 (0.08), p < .05; gait speed: -.03 (.01), p < .01). Further adjusting for cognitive factors (SPPB score: explicit memory .31 (.14), p = .03; executive function 0.45 (0.13), p < .01; gait speed: explicit memory 0.04 (0.02), p = .03; executive function 0.06 (0.02), p < .01) moderated the relationships between number of metabolic risk factors and mobility. CONCLUSION: The relationship between metabolic risk factors and mobility may be moderated by cognitive performance, specifically through executive function and explicit memory.
OBJECTIVE: Mobility limitation and cognitive decline are related. Metabolic syndrome (MetS), the clustering of three or more cardiovascular risk factors, is associated with decline in both mobility and cognition. However, the interrelationship among MetS, mobility, and cognition is unknown. This study investigated a proposed pathway where cognition moderates the relationship between MetS and Mobility. METHOD: Adults ages 45-90 years were recruited. MetS risk factors and mobility performance (Short Physical Performance Battery (SPPB) and gait speed) were evaluated. Cognition was assessed using a comprehensive neuropsychological battery. A factor analysis of neuropsychological test scores yielded three factors: executive function, explicit memory, and semantic/contextual memory. Multivariable linear regression models were used to examine the relationship among MetS, mobility, and cognition. RESULTS: Of the 74 participants (average age 61 ± 9 years; 41% female; 69% White), 27 (36%) participants manifested MetS. Mean SPPB score was 10.9 ± 1.2 out of 12 and gait speed was 1.0 ± 0.2 m/s. There were no statistically significant differences in mobility by MetS status. However, increase in any one of the MetS risk factors was associated with decreased mobility performance after adjusting for age and gender (SPPB score: β (SE) -.17 (0.08), p < .05; gait speed: -.03 (.01), p < .01). Further adjusting for cognitive factors (SPPB score: explicit memory .31 (.14), p = .03; executive function 0.45 (0.13), p < .01; gait speed: explicit memory 0.04 (0.02), p = .03; executive function 0.06 (0.02), p < .01) moderated the relationships between number of metabolic risk factors and mobility. CONCLUSION: The relationship between metabolic risk factors and mobility may be moderated by cognitive performance, specifically through executive function and explicit memory.
Authors: Mette M Pedersen; Nicole E Holt; Laura Grande; Laura A Kurlinski; Marla K Beauchamp; Dan K Kiely; Janne Petersen; Suzanne Leveille; Jonathan F Bean Journal: J Gerontol A Biol Sci Med Sci Date: 2014-05-05 Impact factor: 6.053
Authors: Audrey M Tiehuis; Yolanda van der Graaf; Willem P T M Mali; Koen Vincken; Majon Muller; Mirjam I Geerlings Journal: Diabetes Care Date: 2014-06-19 Impact factor: 19.112
Authors: Brenda W J H Penninx; Barbara J Nicklas; Anne B Newman; Tamara B Harris; Bret H Goodpaster; Suzanne Satterfield; Nathalie de Rekeneire; Kristine Yaffe; Marco Pahor; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-20 Impact factor: 6.053